I

Imagene AI

32 employees

Imagene provides AI-based molecular testing for cancer, detecting in real-time, a broad range of cancerous biomarkers from the biopsy image

Basic info

Industry

hospitals and health care

Sectors

Biotechnology
Health Diagnostics
Health Care
Artificial Intelligence

Date founded

2020

Funding rounds raised

Total raised

$3M

from 1 investors over 1 rounds

I

Imagene AI raised $3M on May 2, 2022

Investors: Blumberg Capital

FAQ